Dare Bioscience Cash Flow Statement (2013-2025) | DARE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.14M	-7.36M	-4.68M	-5.39M	-4.56M	-3.83M	-3.67M	-1.47M
Depreciation and Depletion (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M
Share-based Compensation (Quarter)	0.37M	0.41M	0.44M	0.39M	0.53M	0.54M	0.56M	0.53M	0.62M	0.65M	0.64M	0.62M	0.63M	0.56M	0.52M	0.49M	0.38M	0.36M	0.40M	0.36M
Gains from Investment Securities (Quarter)	0.31M		-0.26M	0.26M	1.04M	-1.14M	0.68M		0.17M	-0.17M			0.40M			0.60M	-0.01M	0.45M		0.40M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-8.38M	-11.79M	1.32M	-9.92M	-12.34M	-8.45M	8.60M	-5.90M	-16.12M	-6.59M	-7.97M	-8.18M	-6.81M	12.90M	-5.92M	5.31M	-5.50M	-5.40M	-0.43M	1.44M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)													659.00	0.02M			0.02M	-0.01M	0.12M
Depreciation & Amortization (CF) (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.16M	0.46M	0.48M	0.53M
Change in Working Capital
Change in Receivables (Quarter)	-0.16M	2.65M	-2.80M	0.99M	0.58M	9.42M	-8.85M	-0.59M		-1.13M	0.56M	-0.18M	0.37M	-0.34M	-0.46M	0.43M		-0.04M	0.18M	0.19M
Change in Account Payables (Quarter)	0.45M	-1.26M	0.39M	1.50M	0.73M	-1.72M	2.36M	-1.45M	0.67M	3.85M	-1.55M	-1.60M	0.65M	-2.13M	-0.86M	0.41M		-0.15M	0.52M	-0.62M
Change in Accured Expenses (Quarter)	-0.84M	1.85M	-0.42M	-0.64M	0.40M	2.81M	-2.21M	6.76M				-8.27M	0.12M	-1.48M	0.16M	1.73M	-1.08M	0.70M	-0.62M	-1.24M
Other Working Capital Changes (Quarter)	-0.22M	0.35M	0.52M	-0.04M				4.19M	-0.10M	0.37M	-0.07M	-0.75M	-1.30M	1.07M	-0.12M	0.36M	-0.67M	0.41M	-0.14M	0.47M
Investing Activities
Capital Expenditures (Quarter)			0.01M		0.00M	816.00	0.06M	0.00M			0.02M	0.61M	0.01M	0.29M	-0.28M	0.49M	0.16M	0.17M	-0.33M	0.39M
Sales of Property, Plant and Equipment (Quarter)
Cash from Investing Activities (Quarter)			-0.01M		-0.00M	-816.00	-0.06M	-0.00M			-0.02M	-0.61M	-0.01M	-0.29M	0.28M	-0.56M	-0.16M	0.15M	-0.17M	-0.21M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	11.37M	13.25M	35.22M	16.00M		1.34M	0.00M	-1.00	1.30M	0.45M	8.58M	5.31M	0.01M	0.12M	0.44M	-0.21M	0.25M	-0.04M	18.65M	0.42M
Additional items
Exchange Rate Effect (Quarter)	-0.01M	-0.01M	-0.06M	0.02M	-0.01M	-0.14M	-0.23M	0.18M	-0.02M	-0.03M	-0.02M	0.06M	-0.04M	0.01M	0.02M	-0.07M	0.01M	0.01M	0.01M	-0.03M
Change in Cash (Quarter)	2.99M	1.45M	36.46M	6.10M	-12.36M	-7.25M	8.32M	-5.72M	-14.84M	-6.17M	0.57M	-3.42M	-6.85M	12.75M	-5.18M	4.47M	-5.37M	-5.29M	18.04M	1.64M
Free Cash Flow (Quarter)	-8.38M	-11.79M	1.31M	-9.92M	-12.35M	-8.45M	8.55M	-5.90M	-16.12M	-6.59M	-8.00M	-8.79M	-6.82M	12.62M	-5.64M	4.82M	-5.66M	-5.57M	-0.10M	1.06M
Net Cash Flow (Quarter)	3.00M	1.46M	36.52M	6.09M	-12.35M	-7.11M	8.55M	-5.90M	-14.82M	-6.13M	0.58M	-3.48M	-6.81M	12.73M	-5.21M	4.53M	-5.41M	-5.29M	18.05M	1.66M

Research Tools

Dare Bioscience Cash Flow Statement (2013-2025) | DARE

Create an account

Sign In

Reset Password